YouthBio Therapeutics
PrivateTotal Funding Raised
$1.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
YouthBio Therapeutics is a biotechnology company that develops tissue-specific gene therapies using partial cellular reprogramming to treat age-related diseases, with an initial focus on Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YouthBio Therapeutics Comparables
Compare YouthBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turn Biotechnologies | 79% | |
| Rejuvenate Bio | 77% | |
| Life Biosciences | 76% |
YouthBio Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 101% MoM, reaching 1K.
- May 20, 2026
Monthly visitors grew 99% MoM.
YouthBio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about YouthBio Therapeutics's valuation, stock price, and market status.
Is YouthBio Therapeutics a public or private company?
YouthBio Therapeutics is a private company.
What is the current stock price of YouthBio Therapeutics?
YouthBio Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is YouthBio Therapeutics worth (valuation)?
Valuation information for YouthBio Therapeutics is not publicly available.
Can I buy YouthBio Therapeutics stock?
YouthBio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was YouthBio Therapeutics's last funding round?
Funding round information for YouthBio Therapeutics is not publicly available.
Who are the main investors in YouthBio Therapeutics?
Investor information for YouthBio Therapeutics is not publicly disclosed.
Will YouthBio Therapeutics IPO soon?
No public IPO plans have been announced for YouthBio Therapeutics.
How can I track YouthBio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor YouthBio Therapeutics's secondary market activity and sign up for updates.